Senator Investment Group LP Biomarin Pharmaceutical Inc Transaction History

Senator Investment Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$80.93 - $108.63 $40.5 Million - $54.3 Million	-500,000 Reduced 76.92%	150,000 $15.5 Million
Q3 2022 Nov 10, 2022	SELL	$82.16 - $96.94 $16.4 Million - $19.4 Million	-200,000 Reduced 23.53%	650,000 $55.1 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $60.8 Million - $73.8 Million	850,000 New	850,000 $70.4 Million
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $93.9 Million - $106 Million	-1,000,000 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$76.01 - $99.03 $76 Million - $99 Million	1,000,000 New	1,000,000 $94.2 Million
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $56.5 Million - $66.6 Million	-700,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $56.4 Million - $66.5 Million	700,000	700,000 $65.1 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

Stay updated on Senator Investment Group LP with notifications on news.